Author

Nitin Pal Kalia

National Institute of Pharmaceutical Education and ResearchORCID 0000-0003-4346-6567Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:human· 2 Assay:metabolomics· 1

Frequent Co-Authors

Arnab RoyiD· 3 shared Puja Kumari AgniveshiD· 3 shared Shashikanta SauiD· 3 shared Aman Dalal· 1 shared Anamika SharmaiD· 1 shared Deepak Kumar SharmaiD· 1 shared Harshada Anil BhaleraoiD· 1 shared Kishan Kumar Parida· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Arnab RoyORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintJun 8, 2026

Exploiting NDH-2 Vulnerability: Quinolines as Antitubercular Agents

Shashikanta Sau, Rohit Kumar, Arnab Roy…·Nitin Pal Kalia

This study identifies quinoline derivatives as antitubercular agents targeting NDH-2, showing efficacy against multidrug-resistant Mycobacterium tuberculosis.

DOI 10.64898/2026.06.08.730781

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintNov 25, 2025

Repurposing ethacridine as a potent MMPL3 Inhibitor for the treatment of tuberculosis

Puja Kumari Agnivesh, Arnab Roy, Shashikanta Sau…·Nitin Pal Kalia

This paper identifies ethacridine as a potent inhibitor of MmpL3, effective against drug-sensitive and resistant tuberculosis strains.

DOI 10.1101/2025.11.25.690360

experimental assaydrug response / drug discovery

𝕏 PostBluesky

MicrobiologybioRxivPreprintNov 23, 2025

Targeting Metabolic Vulnerabilities: Valinomycin Augments the Potency of Bioenergetic Inhibitors in Combatting Drug-Resistant and Dormant Mycobacterium tuberculosis

Arnab Roy, Satish Kushwah, Shashikanta Sau…·Nitin Pal Kalia

This study shows that valinomycin enhances the effectiveness of bioenergetic inhibitors against drug-resistant and dormant Mycobacterium tuberculosis by disrupting the proton motive force.

DOI 10.1101/2025.11.23.690070

humanmetabolomics

𝕏 PostBluesky